870540

Artivion, Inc — FEI 3001451326

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 19, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kennesaw, GA (United States)

Citations

IDCFRDescription
1241121 CFR 1271.260(a)Contamination, mix ups, improper release
1471021 CFR 820.150Lack of or inadequate procedures for storage.
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
311821 CFR 820.75(a)Documentation
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
312821 CFR 820.90(a)Nonconforming product control
313921 CFR 820.140Lack of or inadequate procedures for handling
317221 CFR 820.198(c)Investigation of device failures
319221 CFR 820.30(g)Design validation - user needs and intended uses
322621 CFR 820.70(g)(1)Maintenance schedule, Lack of or inadequate schedule
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
367121 CFR 820.25(a)Personnel
369621 CFR 820.100(b)Documentation
44721 CFR 820.40Lack of procedures, or not maintained
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures